284 related articles for article (PubMed ID: 29503090)
1. Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein.
Young JE; Fong LK; Frankowski H; Petsko GA; Small SA; Goldstein LSB
Stem Cell Reports; 2018 Mar; 10(3):1046-1058. PubMed ID: 29503090
[TBL] [Abstract][Full Text] [Related]
2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
3. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
[TBL] [Abstract][Full Text] [Related]
4. The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport.
Bhalla A; Vetanovetz CP; Morel E; Chamoun Z; Di Paolo G; Small SA
Neurobiol Dis; 2012 Jul; 47(1):126-34. PubMed ID: 22516235
[TBL] [Abstract][Full Text] [Related]
5. Depletion of the AD Risk Gene SORL1 Selectively Impairs Neuronal Endosomal Traffic Independent of Amyloidogenic APP Processing.
Knupp A; Mishra S; Martinez R; Braggin JE; Szabo M; Kinoshita C; Hailey DW; Small SA; Jayadev S; Young JE
Cell Rep; 2020 Jun; 31(9):107719. PubMed ID: 32492427
[TBL] [Abstract][Full Text] [Related]
6. Impaired axonal retrograde trafficking of the retromer complex augments lysosomal deficits in Alzheimer's disease neurons.
Tammineni P; Jeong YY; Feng T; Aikal D; Cai Q
Hum Mol Genet; 2017 Nov; 26(22):4352-4366. PubMed ID: 28973312
[TBL] [Abstract][Full Text] [Related]
7. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic enhancement of retromer rescues endosomal pathology induced by defects in the Alzheimer's gene SORL1.
Mishra S; Knupp A; Kinoshita C; Williams CA; Rose SE; Martinez R; Theofilas P; Young JE
Stem Cell Reports; 2023 Dec; 18(12):2434-2450. PubMed ID: 37949073
[TBL] [Abstract][Full Text] [Related]
9. High glucose-mediated VPS26a down-regulation dysregulates neuronal amyloid precursor protein processing and tau phosphorylation.
Chae CW; Choi GE; Jung YH; Lim JR; Cho JH; Yoon JH; Han HJ
Br J Pharmacol; 2022 Aug; 179(15):3934-3950. PubMed ID: 35297035
[TBL] [Abstract][Full Text] [Related]
10. Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.
Ułamek-Kozioł M; Pluta R; Bogucka-Kocka A; Januszewski S; Kocki J; Czuczwar SJ
Pharmacol Rep; 2016 Jun; 68(3):582-91. PubMed ID: 26940197
[TBL] [Abstract][Full Text] [Related]
11. The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease.
Qureshi YH; Berman DE; Marsh SE; Klein RL; Patel VM; Simoes S; Kannan S; Petsko GA; Stevens B; Small SA
Cell Rep; 2022 Jan; 38(3):110262. PubMed ID: 35045281
[TBL] [Abstract][Full Text] [Related]
12. The Alzheimer's gene SORL1 is a regulator of endosomal traffic and recycling in human neurons.
Mishra S; Knupp A; Szabo MP; Williams CA; Kinoshita C; Hailey DW; Wang Y; Andersen OM; Young JE
Cell Mol Life Sci; 2022 Feb; 79(3):162. PubMed ID: 35226190
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.
Harasta AE; Ittner LM
Adv Neurobiol; 2017; 15():3-29. PubMed ID: 28674976
[TBL] [Abstract][Full Text] [Related]
15. Retromers in Alzheimer's disease.
Siegenthaler BM; Rajendran L
Neurodegener Dis; 2012; 10(1-4):116-21. PubMed ID: 22398391
[TBL] [Abstract][Full Text] [Related]
16. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype.
Li JG; Blass BE; Praticò D
J Alzheimers Dis; 2023; 91(1):463-469. PubMed ID: 36442197
[TBL] [Abstract][Full Text] [Related]
18. Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer's disease in an induced neuron.
Kim H; Yoo J; Shin J; Chang Y; Jung J; Jo DG; Kim J; Jang W; Lengner CJ; Kim BS; Kim J
Brain; 2017 Aug; 140(8):2193-2209. PubMed ID: 28899010
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
20. The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders.
Berman DE; Ringe D; Petsko GA; Small SA
Neurotherapeutics; 2015 Jan; 12(1):12-8. PubMed ID: 25472693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
